A machine-learning powered liquid biopsy predicts response to paclitaxel plus ramucirumab in advanced gastric cancer: results from the prospective IVY trial

Related articles

1. Prospective Germline Exome and Machine Learning-Based Risk Score Identify Predictive and PrognosticBiomarkers of Immunotherapy Outcomes in Advanced Non-Small Cell Lung Cancer

   This article has 15 authors:

   1. Andrea González-Hernández
   2. Alberto Ríos
   3. Juan Luis Onieva
   4. Alexandra Cantero
   5. Marina Rivero-Aguilar
   6. Guillermo Paz-López
   7. Antonio Rueda-Dominguez
   8. María Garrido-Barros
   9. Beatriz Martínez-Gálvez
   10. Juan Zafra
   11. Laura Cristina Figueroa-Ortiz
   12. Elisabeth Pérez-Ruiz
   13. José Carlos Benitez
   14. Isabel Barragan
   15. Javier Oliver

2. A Multicenter Machine Learning Model Incorporating Circulating Tumor Cells for Postoperative Recurrence Prediction in Localized Renal Cell Carcinoma

   This article has 21 authors:

   1. Zihao Li
   2. Chunzhi Qi
   3. Yue Chong
   4. Qiang Wei
   5. Shaogang Wang
   6. Jianbin Bi
   7. Jinkai Shao
   8. Xiaoping Zhang
   9. Xin Gou
   10. Wenhao Shen
   11. Weiyang He
   12. Xiaoming Cao
   13. Wei Xiong
   14. Guojun Chen
   15. Xiaojian Yang
   16. Jianxin Qiu
   17. Yingyi Li
   18. Jianzhou Liu
   19. Yuan Shen
   20. Tie Chong
   21. Zhenlong Wang

3. The Value of LAR in Predicting Neoadjuvant Therapy Response and Prognosis in HER-2-Positive Breast Cancer

   This article has 5 authors:

   1. Xiaojing Li
   2. Xin Xin
   3. Wenjing Xiong
   4. Haoyue zhang
   5. Yue Zhang